Due to triplication and overexpression of the gene for amyloid precursor protein and other genes on chromosome 21, individuals with Down Syndrome (DS) show neuropathologies of AD at an earlier age than the typical population, and about half of adults with DS develop AD. Yet there is wide phenotypic variation in adults with DS and many do not develop AD. This study proposes to use previously biobanked samples towards identifying factors that contribute to resilience to AD in adults with DS. The project will reprogram established fibroblast lines from older DS subjects with and without concomitant AD into induced pluripotent stem cells (iPSCs) and then differentiate these iPSCs into neurons and then into cortical organoids (mixed cortical neuron and astrocyte 3D culture). These organoids will be used to perform transcriptomic analysis and to examine differences in neuronal development and function. Specifically, this project will use a subset of the biobanked samples that examined over 500 adults with DS longitudinally to investigate DS-AD. We will: (1) reprogram established fibroblasts lines from older DS subjects with or without DS-AD into iPSCs, and then use these iPSCs to investigate: (1) the effects of neuronal development on DS-AD; (2) differential gene expressions and eQTL; and (3) the role of a novel gene, WWOX, in DS-AD. This study will generate resources that will enable researchers to perform functional genomic studies following identification of protective and putative genes in DS-AD.

Agency
National Institute of Health (NIH)
Institute
National Center for Advancing Translational Sciences (NCATS)
Type
Linked Specialized Center Cooperative Agreement (UL1)
Project #
3UL1TR001873-04S1
Application #
9932779
Study Section
Special Emphasis Panel (ZTR1)
Program Officer
Talbot, Bernard
Project Start
2016-07-01
Project End
2021-05-31
Budget Start
2019-09-18
Budget End
2020-05-31
Support Year
4
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Columbia University (N.Y.)
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
621889815
City
New York
State
NY
Country
United States
Zip Code
10032
Butler, Alex; Wei, Wei; Yuan, Chi et al. (2018) The Data Gap in the EHR for Clinical Research Eligibility Screening. AMIA Jt Summits Transl Sci Proc 2017:320-329
Zahodne, Laura B; Schupf, Nicole; Brickman, Adam M (2018) Control beliefs are associated with preserved memory function in the face of low hippocampal volume among diverse older adults. Brain Imaging Behav 12:1112-1120
Shechter, Ari; Kim, Elijah Wookhyun; St-Onge, Marie-Pierre et al. (2018) Blocking nocturnal blue light for insomnia: A randomized controlled trial. J Psychiatr Res 96:196-202
Laferrère, Blandine; Pattou, François (2018) Weight-Independent Mechanisms of Glucose Control After Roux-en-Y Gastric Bypass. Front Endocrinol (Lausanne) 9:530
Mulhern, Maureen S; Stumpel, Constance; Stong, Nicholas et al. (2018) NBEA: Developmental disease gene with early generalized epilepsy phenotypes. Ann Neurol 84:788-795
Fried, Justin; Garan, Arthur R; Shames, Sophia et al. (2018) Aortic root thrombosis in patients supported with continuous-flow left ventricular assist devices. J Heart Lung Transplant 37:1425-1432
Wages, Nolan A; Chiuzan, Cody; Panageas, Katherine S (2018) Design considerations for early-phase clinical trials of immune-oncology agents. J Immunother Cancer 6:81
Moise, Nathalie; Wood, Dallas; Cheung, Ying Kuen K et al. (2018) Patient preferences for personalized (N-of-1) trials: a conjoint analysis. J Clin Epidemiol 102:12-22
Truby, Lauren K; Garan, A Reshad; Givens, Raymond C et al. (2018) Ventricular Assist Device Utilization in Heart Transplant Candidates: Nationwide Variability and Impact on Waitlist Outcomes. Circ Heart Fail 11:e004586
Rizvi, Batool; Narkhede, Atul; Last, Briana S et al. (2018) The effect of white matter hyperintensities on cognition is mediated by cortical atrophy. Neurobiol Aging 64:25-32

Showing the most recent 10 out of 84 publications